Novel domain-specific language enhances gRNA optimization for TP53, indicating rapid and efficient genome engineering.
The CRISPR-Cas9 system has revolutionized genome engineering, but its clinical and research success hinges on the design of highly efficient and specific guide RNAs (gRNAs). This design process presents a complex multi-objective optimization challenge. Current computational approaches often rely on single-pass prediction models or require researchers to build bespoke, difficult-to-maintain scripting pipelines for iterative discovery workflows. Here, we introduce GeneForgeLang (GFL), a novel domain-specific language (DSL) designed to declaratively specify and orchestrate advanced AI-driven workflows in genomics. We demonstrate GFL's capabilities by applying its high-level guided_discovery abstraction to the problem of optimizing gRNAs for the human tumor suppressor gene TP53. Our workflow, defined in a single, readable GFL script, autonomously orchestrates an iterative cycle of candidate generation, predictive evaluation using deep learning models, and active learning-based selection. In just 5 cycles, the system efficiently evaluated 100 informative candidates, converging on solutions with near-optimal predicted performance scores (top score: 0.9859). GFL represents a new paradigm for enhancing the reproducibility, composability, and speed of computational research in the life sciences.
No takes yet. Share an insight, caveat, or question.
Manuel Menéndez‐González (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: